LGD4033(Ligandrol)Sarms Powder Bodybuilding CAS:1165910-22-4

    What is LGD-4033 Powder?

    LGD-4033 is a non-steroidal, orally bioavailable compound meticulously designed to selectively bind to androgen receptors (AR) in specific tissues. Synthesized by Ligand Pharmaceuticals (hence "Ligandrol") and initially explored for conditions like muscle wasting and osteoporosis, its potent anabolic properties quickly captured the attention of the athletic community. In its raw powder form, LGD-4033 presents as a fine, white to off-white crystalline substance. This form necessitates precise handling, accurate measurement (typically using milligram scales), and dissolution in a suitable solvent (like PEG-400 or ethanol) for accurate oral dosing in research settings. Crucially, it is not approved for human consumption by any major regulatory body (FDA, EMA, etc.) and is sold strictly as a research chemical.

    1.High Selectivity: This is LGD-4033's cornerstone feature. It exhibits a strong affinity for ARs in muscle and bone tissue, while demonstrating significantly lower binding affinity and activation in tissues like the prostate, skin (causing acne), scalp (causing male pattern baldness), and liver compared to traditional steroids. This selectivity underpins the promise of muscle growth without certain classic AAS side effects.

    2.Potent Anabolic Activity: Ligandrol is renowned for its potency. Studies (primarily preclinical) indicate its anabolic effect is substantial, often compared favorably to potent steroids like oxandrolone in muscle-building potential, gram for gram.

   3.Oral Bioavailability: Unlike many injectable steroids, LGD-4033 is effective when administered orally. Its powder form allows researchers to explore various administration protocols efficiently.

    4.Stability: The raw powder, when stored correctly (cool, dark, dry place, often under inert gas like argon), exhibits good chemical stability, allowing for long-term storage for research purposes.

    5.Solubility Challenges: Pure LGD-4033 powder has limited solubility in water. Effective research requires dissolving it in solvents like Dimethyl Sulfoxide (DMSO) for cellular studies, or PEG-400/propylene glycol/ethanol mixtures for creating oral solutions. Improper dissolution leads to inaccurate dosing.

    6.Research Chemical Status: This is paramount. The powder lacks pharmaceutical-grade purity assurance. Quality, concentration, and contaminants vary wildly between suppliers, posing significant risks. Third-party lab testing (COA - Certificate of Analysis) is essential, though not foolproof.

    Within the research paradigm that governs its legal sale, LGD-4033 powder is investigated for potential applications relevant to bodybuilding goals:

    1.Muscle Hypertrophy Research: Its primary investigated application is stimulating significant increases in lean muscle mass and strength, particularly under conditions of resistance training simulation.

    2.Muscle Preservation Studies: Research explores its efficacy in preventing or mitigating muscle loss during phases of caloric deficit ("cutting") or periods of forced inactivity (injury models).

    3.Bone Density Enhancement: Studies examine its potential to increase bone mineral density, a factor relevant to overall structural health under heavy loading.

    4.Fat Loss Modulation: While not a direct fat burner, research suggests the increased metabolic rate associated with significant muscle gain, combined with potential mild nutrient partitioning effects, may contribute to reductions in fat mass during bulking phases or improve body composition during recomping protocols.

    The theoretical and observed benefits driving LGD-4033's popularity include:

    1.Substantial Lean Muscle Gains: Users/researchers consistently report notable increases in lean body mass, often exceeding those achievable with natural training alone, typically within 6-8 week cycles. Gains appear "dryer" and less water-retentive than some steroids.

    2.Significant Strength Increases: Enhanced muscle mass directly translates to measurable increases in strength across major compound lifts.

    3.Improved Muscle Hardness and Density: The quality of muscle gained is often described as dense and hard, contributing to a more defined physique.

    4.Enhanced Recovery: Reports suggest reduced muscle soreness and faster recovery between training sessions, enabling higher training frequency and intensity.

    5.Potential Bone Strengthening: While less a direct bodybuilding goal, increased bone density is a positive systemic effect.

    6.Oral Convenience: Eliminates the need for injections.

    7.Reduced Androgenic Side Effects (Compared to AAS): The potential for significantly less acne, accelerated hair loss (in predisposed individuals), and prostate enlargement compared to moderate/high dose steroids is a major draw. However, this does NOT equate to being side-effect free.

    Determining precise human-equivalent dosages from preclinical data is challenging. Anecdotal reports and limited human trial data suggest:

    ●Effective Research Range: 1mg to 10mg per day.

    ●Common "Sweet Spot": 5mg to 10mg per day is frequently cited for significant anabolic effects. Higher doses (e.g., 15mg+) show diminishing returns and a sharp increase in side effect likelihood.

    ●Conservative Approach: Many experienced researchers start at 2.5mg or 5mg daily to assess individual tolerance before potentially increasing.

    ●Dosing Protocol: Typically administered once daily due to its half-life. Timing (morning vs. pre-workout) is largely anecdotal, with no strong scientific consensus for performance enhancement. Consistency is key.

    ●Crucial Note: Handling raw powder requires extreme precision. Microgram scales are essential. Inaccurate measurement leads to significant overdosing or underdosing. Proper dissolution is critical for consistent dosing and absorption.

    Cycle length is a critical factor in managing side effects, particularly suppression:

    ●Typical Cycle Length: 8 weeks is widely considered the maximum recommended duration for minimizing significant suppression and allowing for more straightforward recovery.

    ●Shorter Cycles: 6-week cycles are increasingly popular, especially for those sensitive to suppression or using it for cutting/recomping, offering a potentially better balance of gains vs. recovery difficulty.

    ●Longer Cycles (Risky): Extending beyond 8 weeks significantly increases the risk of profound testosterone suppression, liver enzyme elevation, lipid profile deterioration, and a much harder recovery. 12+ week cycles are strongly discouraged without extensive monitoring and medical oversight (which is virtually nonexistent in this context).

    ●Frequency: Significant time off (equal to or preferably longer than the cycle duration) is crucial to allow the HPTA to recover before considering another cycle.

    ●Estimated Half-Life: LGD-4033 has a relatively long elimination half-life in humans, estimated to be between 24 to 36 hours based on available pharmacokinetic data.

    ●Implications:

    ○Once-Daily Dosing: The long half-life allows for stable blood levels with a single daily dose, simplifying the protocol.

    ○Accumulation: Due to the half-life, the compound will accumulate in the system over the first week or two, reaching steady-state concentrations.

    ○Post-Cycle Presence: The drug remains detectable in the system for several days after the last dose (approximately 5-7 half-lives for near-complete elimination = 5-7 days). This impacts the timing of Post-Cycle Therapy (PCT) initiation.

    This is arguably the most complex and debated aspect of SARM use, including LGD-4033. Suppression of the Hypothalamic-Pituitary-Testicular Axis (HPTA) is a dose and duration-dependent reality, not a mere possibility.

    ●Nature of Suppression: LGD-4033 suppresses the body's natural production of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH), leading to decreased endogenous testosterone production. Symptoms can include low libido, fatigue, lethargy, mood changes, and potential loss of gains.

    ●PCT Necessity: The need for PCT is highly individual and depends on:

    ○Cycle dose and duration (Higher/longer = More suppression)

    ○Individual sensitivity to suppression

    ○Pre-cycle baseline hormone levels

    ○Blood work results (mid-cycle and post-cycle)

    ●PCT Components (Used in Research/Restoration Protocols):

    ○SERMs (Selective Estrogen Receptor Modulators): Tamoxifen (Nolvadex) and Clomiphene (Clomid) are the most common. They work by blocking estrogen receptors in the hypothalamus/pituitary, tricking the body into increasing GnRH production, which stimulates LH/FSH release, thereby jumpstarting natural testosterone production. Typical research doses might involve Tamoxifen 10-20mg/day or Clomid 25-50mg/day for 4-6 weeks, starting 3-7 days after the last LGD dose.

    ○Aromatase Inhibitors (AIs): Like Anastrozole (Arimidex). Generally NOT recommended for SARM PCT. SARMs don't aromatize to estrogen. AIs can crash estrogen levels, leading to joint pain, low mood, and impaired recovery, unless a specific estrogen-related issue (like pre-existing gyno flaring due to the testosterone/estrogen imbalance during suppression) is present and requires targeted treatment.

    ●The Controversy: Some argue that after moderate cycles (e.g., 5mg for 8 weeks), natural recovery is sufficient for younger individuals without pre-existing issues. However, given the variability in suppression and the significant impact of low testosterone, having a SERM-based PCT protocol on hand and being prepared to use it based on symptoms and (ideally) blood work is the most prudent approach. Never start PCT without understanding the compounds and their potential side effects.

    ●Blood Work Imperative: Pre-cycle, mid-cycle (optional but informative), and post-cycle (4-6 weeks after PCT completion) blood tests (Total Testosterone, Free Testosterone, LH, FSH, Estradiol, Liver Enzymes ALT/AST, Lipids HDL/LDL) are the only reliable way to gauge suppression severity and recovery success.

    1.Testosterone Suppression: Guaranteed at bodybuilding doses. Severity varies but can be significant. Ignoring this leads to prolonged low-T symptoms.

    2.Liver Stress: While generally considered less hepatotoxic than oral steroids, dose-dependent elevations in liver enzymes (ALT/AST) are frequently observed. Pre-existing conditions or combining with other hepatotoxic substances (including alcohol) increases risk.

    3.Lipid Profile Impact: Often causes unfavorable changes: lowering HDL ("good" cholesterol) and potentially raising LDL ("bad" cholesterol), increasing cardiovascular risk long-term.

    4.Purity & Contamination: The unregulated powder market is rife with under-dosed, over-dosed, mislabeled, and contaminated products. Heavy metals, solvents, or other undisclosed SARMs/steroids are real dangers. Third-party testing (COA) is non-negotiable but still not absolute security.

    5.Lack of Long-Term Safety Data: The long-term consequences (5, 10, 20+ years) of SARM use, especially initiated young, are completely unknown.

    6.Vascularity & Pumps: Some users report intense pumps and vascularity, potentially linked to fluid shifts or blood pressure changes.

    7.Headaches & Lethargy: Reported side effects, possibly related to suppression or individual response.

    8.Legality & Ethics: Banned by WADA and most sports organizations. Legal status varies by country, often existing in a grey area as a "research chemical" not for consumption. Use in competition is unethical.

Trade names	LGD4033,Ligandrol,VK5211
CAS	1165910-22-4
Molar mass	338.253
MF	C14H12F6N2O
Purity	Above 98%
Apprarance	White crystal powder

 

 

Any needs, please contact us

Email: Jasonraws106@gmail.com

WhatsApp: +86-15572565525
Telegram: +86-15871669785

   

                                   

 

    LGD-4033 powder represents a potent research chemical with significant, selective anabolic potential attractive to bodybuilders seeking alternatives to traditional steroids. Its features-high selectivity, oral bioavailability, and muscle-building potency-drive its popularity. Potential benefits include substantial lean mass gains, strength increases, and improved recovery. However, these come with unequivocal risks: guaranteed testosterone suppression, potential liver stress, adverse lipid changes, and the ever-present danger of impure products.

    Responsible engagement demands meticulous research, strict adherence to conservative dosing (5-10mg/day), short cycle lengths (6-8 weeks), preparation for SERM-based PCT based on individual response and blood work, and absolute insistence on third-party verified purity. Ignoring these risks, particularly the certainty of HPTA suppression and the unpredictability of raw powder quality, is reckless. LGD-4033 is a powerful research tool, not a benign shortcut, and its use demands respect for its potency and potential consequences. Prioritize health, accurate information, and verified quality above all else.

Hot Tags: lgd4033(ligandrol)sarms powder bodybuilding cas:1165910-22-4, China lgd4033(ligandrol)sarms powder bodybuilding cas:1165910-22-4 manufacturers, suppliers, factory, GW501516, MK677, LGD3303, LGD4033 Treat Muscular Dystrophy and Osteoporosis, AC-262, AC 262 Selective androgen receptor modulator